Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

Open Access 01-07-2015 | Basic Science

The expression of Mas-receptor of the renin–angiotensin system in the human eye

Authors: A. Vaajanen, G. Kalesnykas, H. Vapaatalo, H. Uusitalo

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 7/2015

Abstract

Purpose

The local renin–angiotensin system has been held to be expressed in many organs, including the eye. It has an important role in the regulation of local fluid homeostasis, cell proliferation, fibrosis, and vascular tone. Mas-receptor (Mas-R) is a potential receptor acting mainly opposite to the well-known angiotensin II receptor type 1. The aim of this study was to determine if Mas-R is expressed in the human eye.

Methods

Seven enucleated human eyes were used in immunohistochemical detection of Mas-R and its endogenous ligand angiotensin (1–7) [Ang(1–7)]. Both light microscopy and immunofluorescent detection methods were used. A human kidney preparation sample was used as control.

Results

The Mas-R was found to have nuclear localization, and localized in the retinal nuclear layers and in the structures of the anterior segment of the eye. A cytoplasmic immunostaining pattern of Ang(1–7) was found in the inner and outer nuclear and plexiform layers of the retina and in the ciliary body.

Conclusion

To the best of our knowledge, this is the first report showing Mas-R expression in the human eye. Its localization suggests that it may have a role in physiological and pathological processes in the anterior part of the eye and in the retina.

Bader M, Peters J, Baltatu O, Müller DN, Luft FC, Ganten D (2001) Tissue renin–angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79:76–102PubMedCrossRef

Kramkowski K, Mogielnicki A, Buczko W (2006) The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 57:529–539PubMed

Young D, Waitches G, Birchmeier C, Fasano O, Wigler M (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45(5):711–719PubMedCrossRef

Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin (1–7) is an endogenous ligand for the G-protein-coupled receptor Mas. Proc Natl Acad Sci U S A 8:8258–8263CrossRef

Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin–angiotensin systems. Review. Physiol Rev 86:747–803PubMedCrossRef

Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF (1986) Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A 83:7552–7556PubMedCentralPubMedCrossRef

Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS (2012) Review article: the pathophysiological roles of the renin–angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 35:414–428PubMedCrossRef

Danser AHJ, Derkx FHM, Admiraal PJJ, Deinum J, de Jong PTVM, Schalekamp MADH (1994) Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35:1008–1018PubMed

Foureaux G, Nogueira JC, Nogueira BS, Fulgencio GO, Menezes GB, Fernandes SO, Cardoso VN, Fernandes RS, Oliveira GP, Franca JR, Faraco AA, Raizada MK, Ferreira AJ (2013) Antiglaucomatous effects of the activation of intrinsic angiotensin-converting enzyme 2. Invest Ophthalmol Vis Sci 54:4296–4306PubMedCentralPubMedCrossRef

10.

Giese MJ, Speth RC (2014) The ocular renin–angiotensin system: a therapeutic target for the treatment of ocular disease. Pharmacol Ther 142:11–32PubMedCrossRef

11.

Luhtala S, Vaajanen A, Oksala O, Valjakka J, Vapaatalo H (2009) Activities of angiotensin-converting enzymes 1 (ACE1) and 2 (ACE2) and inhibition by bioactive peptides in porcine ocular tissues. J Ocul Pharmacol 25:23–28CrossRef

12.

Senanayake PD, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E, Nishiyama K, Miura S, Karnik S, Sears JE, Hollyfield JG (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48:3301–3311PubMedCrossRef

13.

Vaajanen A, Luhtala S, Oksala O, Vapaatalo H (2008) Does the renin–angiotensin system also regulate intraocular pressure? Ann Med 10:1–10

14.

Wagner J, Danser AHJ, Derkx FH, de Jong TV, Paul M, Mullins JJ, Schalekamp MA, Ganten D (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme RNA expression in the human eye: evidence for an intraocular renin–angiotensin system. Br J Ophthalmol 80:159–163PubMedCentralPubMedCrossRef

15.

Vaajanen A, Lakkisto P, Virtanen I, Kankuri E, Oksala O, Vapaatalo H, Tikkanen I (2010) Angiotensin receptors in the eyes of arterial hypertensive rats. Acta Ophthalmol 88:431–438PubMedCrossRef

16.

Young D, O'Neill K, Jessell T, Wigler M (1988) Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc Natl Acad Sci U S A 85(14):5339–5342PubMedCentralPubMedCrossRef

17.

Kitaoka T, Sharif M, Hanley MR, Hjelmeland LM (1994) Expression of the MAS proto-oncogene in the retinal pigment epithelium of the rhesus macaque. Curr Eye Res 13(5):345–351PubMedCrossRef

18.

Paulis L, Unger T (2010) Novel therapeutic targets for hypertension. Nat Rev Cardiol 7:431–441PubMedCrossRef

19.

Ferrario CM (2011) ACE2: more of Ang-(1–7) or less Ang II? Curr Opin Nephrol Hypertens 20:1–6PubMedCrossRef

20.

Ferreira AJ, Murça TM, Fraga-Silva RA, Castro CH, Raizada MK, Santos RA (2012) New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2/angiotensin-(1–7)/mas receptor axis. Int J Hypertens 2012:147825PubMedCentralPubMed

21.

Vaajanen A, Vapaatalo H, Kautiainen H, Oksala O (2008) Angiotensin (1–7) reduces intraocular pressure in the normotensive rabbit eye. Invest Ophthalmol Vis Sci 49:2557–2562PubMedCrossRef

22.

Costagliola C, Di Benedetto R, De Caprio L, Verde R, Mastropasqua L (1995) Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol 5:19–25PubMed

23.

Costagliola C, Verolino M, de Rosa ML, Iaccarino G, Ciancaglini M, Mastropasqua L (2000) Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res 71:167–171PubMedCrossRef

24.

Mehta A, Lyer L, Parmar S, Shah G, Goyal R (2010) Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits. Can J Physiol Pharmacol 88:595–600PubMedCrossRef

Title: The expression of Mas-receptor of the renin–angiotensin system in the human eye
Authors: A. Vaajanen
G. Kalesnykas
H. Vapaatalo
H. Uusitalo
Publication date: 01-07-2015
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 7/2015
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-015-2952-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The expression of Mas-receptor of the renin–angiotensin system in the human eye

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2015

Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model

Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation

Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma

Medial rectus muscle elongation, a technique to treat very large-angle esotropia

Mesenchymal stem cells improve healing of the cornea after alkali injury

Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty